BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25721194)

  • 1. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
    Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry.
    Carlier J; Diao X; Scheidweiler KB; Huestis MA
    Clin Chem; 2017 May; 63(5):1008-1021. PubMed ID: 28302730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
    Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
    Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
    Andersson M; Diao X; Wohlfarth A; Scheidweiler KB; Huestis MA
    Rapid Commun Mass Spectrom; 2016 Apr; 30(8):1067-78. PubMed ID: 27003044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry.
    Wohlfarth A; Gandhi AS; Pang S; Zhu M; Scheidweiler KB; Huestis MA
    Anal Bioanal Chem; 2014 Feb; 406(6):1763-80. PubMed ID: 24518903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.
    Doi T; Asada A; Takeda A; Tagami T; Katagi M; Kamata H; Sawabe Y
    J Chromatogr A; 2016 Nov; 1473():83-89. PubMed ID: 27773389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
    Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
    Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
    Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
    Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18.
    Diao X; Carlier J; Zhu M; Huestis MA
    Clin Chem; 2017 Nov; 63(11):1753-1763. PubMed ID: 28821542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol.
    Wang Z; Fong CY; Goh EML; Moy HY; Chan ECY
    J Anal Toxicol; 2023 Jan; 46(9):1016-1024. PubMed ID: 34918103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
    Li J; Liu C; Li T; Hua Z
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Rapid Method for Identification of New Synthetic Cannabinoids in Hair Based on High-Performance Liquid Chromatography-Ion Trap Mass Spectrometry Using a Simplified User Interface.
    Musile G; Palacio C; Murari M; Appolonova S; Tagliaro F
    J Anal Toxicol; 2023 Feb; 47(1):72-80. PubMed ID: 35536611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.